Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Funding

Regulatory  ·  Weekly Digest - 03 October to 09 October 2026
Crescent Biopharma receives FDA IND clearance for CR-002 in Solid tumors

Weekly Digest – October 2026 Weekly Digest – October 2026 05 October 2026: Crescent Biopharma receives FDA IND clearance for CR-002 in Solid tumors Crescent Biopharma announced that the U.S. FDA has cleared the Investigational New Drug application for CR-002, […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 03 October to 09 October 2026
AstraZeneca and Daiichi Sankyo collaborate with Summit Therapeutics to evaluate Datroway plus Ivonescimab across multiple tumor types

Weekly Digest – October 2026 Weekly Digest – October 2026 02 October 2026: AstraZeneca and Daiichi Sankyo collaborate with Summit Therapeutics to evaluate Datroway plus Ivonescimab across multiple tumor types AstraZeneca and Daiichi Sankyo have entered a clinical collaboration with Summit […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 26 September to 02 October 2026
Perioperative Imfinzi plus Enfortumab vedotin received U.S. FDA Priority Review for MIBC

Weekly Digest – October 2026 Weekly Digest – October 2026 25 September 2026: Perioperative Imfinzi plus Enfortumab vedotin received U.S. FDA Priority Review for MIBC AstraZeneca announced that the U.S. FDA has accepted supplemental Biologics License Application for Imfinzi in […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 26 September to 02 October 2026
BL-M05D1 received BTD in China for previously treated advanced Gastric/GEJ cancer

Weekly Digest – October 2026 Weekly Digest – October 2026 28 September 2026: BL-M05D1 received BTD in China for previously treated advanced Gastric/GEJ cancer Biokin Pharma announced that BL-M05D1, its Claudin18.2-directed ADC, has been included in China’s NMPA Breakthrough Therapy […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 26 September to 02 October 2026
Ifinatamab deruxtecan BLA for previously treated extensive-stage SCLC was voluntarily withdrawn in the U.S.

Weekly Digest – October 2026 Weekly Digest – October 2026 25 September 2026: Ifinatamab deruxtecan BLA for previously treated extensive-stage SCLC was voluntarily withdrawn in the U.S. Daiichi Sankyo and MSD announced the voluntary withdrawal of the U.S. BLA seeking […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 26 September to 02 October 2026
AstraZeneca announced an equity investment and clinical collaboration with Summit Therapeutics to advance ADC combinations in cancer

Weekly Digest – October 2026 Weekly Digest – October 2026 28 September 2026: AstraZeneca announced an equity investment and clinical collaboration with Summit Therapeutics to advance ADC combinations in cancer AstraZeneca announced a US$2 billion strategic equity investment in Summit […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 26 September to 02 October 2026
Nurix Therapeutics announced a $7 million milestone achievement under its strategic collaboration with Pfizer

Weekly Digest – October 2026 Weekly Digest – October 2026 29 September 2026: Nurix Therapeutics announced a $7 million milestone achievement under its strategic collaboration with Pfizer Nurix Therapeutics announced the achievement of a US$7 million research milestone under its […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 26 September to 02 October 2026
Dong-A ST and Galux entered a research collaboration to develop AI-designed antibodies for ADC therapeutics

Weekly Digest – October 2026 Weekly Digest – October 2026 01 October 2026: Dong-A ST and Galux entered a research collaboration to develop AI-designed antibodies for ADC therapeutics Dong-A ST and Galux announced a research collaboration to develop novel ADC […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 19 September to 25 September 2026
Enhertu receives CHMP recommendation for adjuvant treatment of HER2-positive early Breast cancer

Weekly Digest – September 2026 Weekly Digest – September 2026 18 September 2026: Enhertu receives CHMP recommendation for adjuvant treatment of HER2-positive early Breast cancer Daiichi Sankyo and AstraZeneca announced that Enhertu has been recommended by the EMA’s CHMP for […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 19 September to 25 September 2026
PADCEV + Keytruda receives positive CHMP opinion for resectable MIBC

Weekly Digest – September 2026 Weekly Digest – September 2026 18 September 2026: PADCEV + Keytruda receives positive CHMP opinion for resectable MIBC Astellas and MSD announced that PADCEV in combination with KEYTRUDA received a positive CHMP opinion for perioperative […]

by Sandhya Ramalingam

Continue Reading
‹ Previous123456789Next ›Last »
Page 5 of 63


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id